Health ❯Pharmaceuticals

Obesity Treatment

Weight Loss Drugs GLP-1 Drugs Alzheimer's Treatment GLP-1 Analogues Retatrutide Clinical Trials Weight-loss Drugs Drug Development Wegovy Injectable Drugs Oral GLP-1 Molecule

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

New Studies Confirm Safety of Semaglutide for Mental Health

Pfizer Advances Daily Weight Loss Pill Amid FDA Rejection of Novo's Insulin

Semaglutide: Beyond Weight Loss to Potential Therapies for Addiction, Dementia, and More

Pfizer Halts Development of Twice-Daily Weight Loss Pill Due to Adverse Side Effects

Novo Nordisk Reports Record Profits as Demand for Weight Loss Drugs Wegovy and Ozempic Surges Amid Global Shortages and Rising Concerns over Illegal Market Sales